Rockefeller Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$134M Sell
329,557
-14,298
-4% -$5.82M 0.29% 64
2025
Q1
$171M Buy
343,855
+55,021
+19% +$27.4M 0.42% 36
2024
Q4
$150M Buy
288,834
+43,983
+18% +$22.9M 0.39% 43
2024
Q3
$151M Buy
244,851
+1,966
+0.8% +$1.22M 0.41% 44
2024
Q2
$134M Buy
242,885
+14,768
+6% +$8.17M 0.38% 50
2024
Q1
$133M Buy
228,117
+20,293
+10% +$11.8M 0.39% 47
2023
Q4
$110M Buy
207,824
+216
+0.1% +$115K 0.37% 56
2023
Q3
$105M Buy
207,608
+8,053
+4% +$4.08M 0.41% 47
2023
Q2
$103M Buy
199,555
+24,240
+14% +$12.6M 0.4% 46
2023
Q1
$101M Sell
175,315
-7,101
-4% -$4.09M 0.43% 42
2022
Q4
$100M Sell
182,416
-5,106
-3% -$2.81M 0.5% 37
2022
Q3
$95.1M Buy
187,522
+11,083
+6% +$5.62M 0.49% 39
2022
Q2
$95.9M Buy
176,439
+17,721
+11% +$9.63M 0.51% 37
2022
Q1
$93.7M Buy
158,718
+11,961
+8% +$7.06M 0.45% 44
2021
Q4
$97.9M Buy
146,757
+7,624
+5% +$5.09M 0.46% 43
2021
Q3
$79.5M Buy
139,133
+18,917
+16% +$10.8M 0.42% 47
2021
Q2
$60.6M Buy
120,216
+24,682
+26% +$12.5M 0.34% 62
2021
Q1
$43.6M Buy
95,534
+11,006
+13% +$5.02M 0.3% 75
2020
Q4
$39.4M Buy
84,528
+20,106
+31% +$9.36M 0.3% 80
2020
Q3
$28.4M Buy
64,422
+7,258
+13% +$3.2M 0.27% 95
2020
Q2
$20.7M Buy
57,164
+7,790
+16% +$2.82M 0.22% 104
2020
Q1
$14M Buy
49,374
+6,554
+15% +$1.86M 0.18% 119
2019
Q4
$13.9M Sell
42,820
-6,490
-13% -$2.11M 0.17% 124
2019
Q3
$14.4M Buy
49,310
+1,432
+3% +$417K 0.19% 106
2019
Q2
$14.1M Buy
47,878
+8,690
+22% +$2.55M 0.2% 99
2019
Q1
$10.7M Buy
39,188
+14,001
+56% +$3.83M 0.15% 112
2018
Q4
$5.64M Buy
25,187
+4,121
+20% +$922K 0.1% 127
2018
Q3
$5.14M Buy
21,066
+1,296
+7% +$316K 0.08% 123
2018
Q2
$4.1M Buy
19,770
+375
+2% +$77.7K 0.07% 130
2018
Q1
$4M Buy
+19,395
New +$4M 0.07% 135